Bolandiol
A 19-nortestosterone prohormone (estra-4-ene-3beta,17beta-diol) that converts to nandrolone in the body. Marketed in supplements before regulation; limited human data, mostly from doping analysis and prohormone-conversion studies.
01 Overview
Bolandiol is a diol precursor to nandrolone, sometimes sold as '19-nor-DHEA'-type prohormone material. On administration it is metabolised toward nandrolone and its metabolites, which is why it produces nandrolone-type anti-doping findings.
Direct human trials are lacking. The compound is understood mainly through its conversion pharmacology and the well-characterised effects of its active metabolite, nandrolone.
02 Mechanism
Acts as a prohormone: enzymatic oxidation converts bolandiol to nandrolone, a 19-nor androgen-receptor agonist with strong anabolic and modest androgenic activity.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Anecdotal | 50–200 mg/day | Oral | Prohormone-era ranges; conversion efficiency low and variable. |
Ester comparison
| Ester | Half-life | Injection freq. | Testosterone by mass |
|---|
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| Nandrolone-type anabolismProduces nandrolone metabolites; effect resembles low-dose nandrolone. | modest | Observational | |
| Joint / recovery comfortUsers report nandrolone-like joint comfort, unverified. | unquantified | Anecdotal |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| HPTA suppressionConversion to nandrolone suppresses endogenous testosterone. | Moderate | Expected | Observational | |
| Long-detectable metabolitesNandrolone metabolites (19-norandrosterone) are detectable for long periods. | Mild | Universal | Observational |